Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2026-05-11 @ 1:33 PM
Study NCT ID:
NCT03261635
Status:
COMPLETED
Last Update Posted:
2017-08-25
First Post:
2017-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ranibizumab Plus Indomethacin
Sponsor:
Università degli Studi di Brescia
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NSAIDs_02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None